Clinical analysis of intra-arterial concurrent chemoradiotherapy for oropharyngeal carcinoma of the anterior, posterior, and superior walls

Mioko Matsuo, Fumihide Rikimaru, Yuichiro Higaki, Kichinobu Tomita

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We reviewed oropharyngeal carcinoma of the anterior, posterior, and superior walls. Clinical features of 34 cases with anterior, posterior, and superior oropharyngeal carcinoma among 93 patients of oropharyngeal carcinoma that we treated in our hospital from January 1997 to October 2005 were analyzed. We treated oropharyngeal carcinoma with concurrent chemoradiotherapy by intra-arterial CBDCA continuous infusion after 1997. In cases of anterior, posterior, and superior wall carcinoma, the disease-specific 3-year survival rates were 55%, 83%, and 100%, and all the cases that successfully received primary radical treatment obtained loco-regional control. On the other hand, two cases died due to postoperative swallowing dysfunction, suggesting that improvement is required. In addition, multiple primary cancers were detected in 48% of the 34 patients. These results suggest that concurrent chemoradiotherapy by intra-arterial continuous infusion for oropharyngeal carcinoma is an effective method.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalToukeibu Gan
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 1 2009

Fingerprint

Chemoradiotherapy
Carcinoma
Intra Arterial Infusions
Carboplatin
Deglutition
Survival Rate
Neoplasms

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Oncology

Cite this

Clinical analysis of intra-arterial concurrent chemoradiotherapy for oropharyngeal carcinoma of the anterior, posterior, and superior walls. / Matsuo, Mioko; Rikimaru, Fumihide; Higaki, Yuichiro; Tomita, Kichinobu.

In: Toukeibu Gan, Vol. 35, No. 1, 01.01.2009, p. 25-30.

Research output: Contribution to journalArticle

@article{7c812d93272b4046bc4cdad8dca426a5,
title = "Clinical analysis of intra-arterial concurrent chemoradiotherapy for oropharyngeal carcinoma of the anterior, posterior, and superior walls",
abstract = "We reviewed oropharyngeal carcinoma of the anterior, posterior, and superior walls. Clinical features of 34 cases with anterior, posterior, and superior oropharyngeal carcinoma among 93 patients of oropharyngeal carcinoma that we treated in our hospital from January 1997 to October 2005 were analyzed. We treated oropharyngeal carcinoma with concurrent chemoradiotherapy by intra-arterial CBDCA continuous infusion after 1997. In cases of anterior, posterior, and superior wall carcinoma, the disease-specific 3-year survival rates were 55{\%}, 83{\%}, and 100{\%}, and all the cases that successfully received primary radical treatment obtained loco-regional control. On the other hand, two cases died due to postoperative swallowing dysfunction, suggesting that improvement is required. In addition, multiple primary cancers were detected in 48{\%} of the 34 patients. These results suggest that concurrent chemoradiotherapy by intra-arterial continuous infusion for oropharyngeal carcinoma is an effective method.",
author = "Mioko Matsuo and Fumihide Rikimaru and Yuichiro Higaki and Kichinobu Tomita",
year = "2009",
month = "1",
day = "1",
doi = "10.5981/jjhnc.35.25",
language = "English",
volume = "35",
pages = "25--30",
journal = "Japanese Journal of Head and Neck Cancer",
issn = "1349-5747",
publisher = "Nihon Tokeibu Gan Gakkai",
number = "1",

}

TY - JOUR

T1 - Clinical analysis of intra-arterial concurrent chemoradiotherapy for oropharyngeal carcinoma of the anterior, posterior, and superior walls

AU - Matsuo, Mioko

AU - Rikimaru, Fumihide

AU - Higaki, Yuichiro

AU - Tomita, Kichinobu

PY - 2009/1/1

Y1 - 2009/1/1

N2 - We reviewed oropharyngeal carcinoma of the anterior, posterior, and superior walls. Clinical features of 34 cases with anterior, posterior, and superior oropharyngeal carcinoma among 93 patients of oropharyngeal carcinoma that we treated in our hospital from January 1997 to October 2005 were analyzed. We treated oropharyngeal carcinoma with concurrent chemoradiotherapy by intra-arterial CBDCA continuous infusion after 1997. In cases of anterior, posterior, and superior wall carcinoma, the disease-specific 3-year survival rates were 55%, 83%, and 100%, and all the cases that successfully received primary radical treatment obtained loco-regional control. On the other hand, two cases died due to postoperative swallowing dysfunction, suggesting that improvement is required. In addition, multiple primary cancers were detected in 48% of the 34 patients. These results suggest that concurrent chemoradiotherapy by intra-arterial continuous infusion for oropharyngeal carcinoma is an effective method.

AB - We reviewed oropharyngeal carcinoma of the anterior, posterior, and superior walls. Clinical features of 34 cases with anterior, posterior, and superior oropharyngeal carcinoma among 93 patients of oropharyngeal carcinoma that we treated in our hospital from January 1997 to October 2005 were analyzed. We treated oropharyngeal carcinoma with concurrent chemoradiotherapy by intra-arterial CBDCA continuous infusion after 1997. In cases of anterior, posterior, and superior wall carcinoma, the disease-specific 3-year survival rates were 55%, 83%, and 100%, and all the cases that successfully received primary radical treatment obtained loco-regional control. On the other hand, two cases died due to postoperative swallowing dysfunction, suggesting that improvement is required. In addition, multiple primary cancers were detected in 48% of the 34 patients. These results suggest that concurrent chemoradiotherapy by intra-arterial continuous infusion for oropharyngeal carcinoma is an effective method.

UR - http://www.scopus.com/inward/record.url?scp=85009636939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009636939&partnerID=8YFLogxK

U2 - 10.5981/jjhnc.35.25

DO - 10.5981/jjhnc.35.25

M3 - Article

AN - SCOPUS:85009636939

VL - 35

SP - 25

EP - 30

JO - Japanese Journal of Head and Neck Cancer

JF - Japanese Journal of Head and Neck Cancer

SN - 1349-5747

IS - 1

ER -